Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

In vitro evaluation of nanoparticles spleen capture.

M Demoy1, J P Andreux, C Weingarten

  • 1Laboratoire de Physico-Chimie, Pharmacotechnie et Biopharmacie, URA CNRS 1218, Faculté de Pharmacie, Université Paris XI, Châtenay-Malabry, France.

Life Sciences
|May 5, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

(Poly-cyanoacrylate) nanomedicines for cancer and beyond: Lessons learned.

Journal of controlled release : official journal of the Controlled Release Society·2021
Same author

Vitamin C-squalene bioconjugate promotes epidermal thickening and collagen production in human skin.

Scientific reports·2020
Same author

Squalenoyl-gemcitabine/edelfosine nanoassemblies: Anticancer activity in pediatric cancer cells and pharmacokinetic profile in mice.

International journal of pharmaceutics·2020
Same author

Antineoplastic busulfan encapsulated in a metal organic framework nanocarrier: first in vivo results.

Journal of materials chemistry. B·2020
Same author

Towards improved HIV-microbicide activity through the co-encapsulation of NRTI drugs in biocompatible metal organic framework nanocarriers.

Journal of materials chemistry. B·2020
Same author

A unique multidrug nanomedicine made of squalenoyl-gemcitabine and alkyl-lysophospholipid edelfosine.

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V·2019

This study introduces an in vitro spleen slice model to investigate nanoparticle uptake by marginal zone macrophages. Results show scavenger receptors and albumin are key in nanoparticle capture, offering a new assay for drug carriers.

Area of Science:

  • Nanomedicine
  • Immunology
  • Cell Biology

Background:

  • Spleen macrophages capture intravenously injected nanoparticles, primarily in the marginal zone.
  • Traditional cell preparation methods damage these macrophages, hindering in vitro study.
  • A novel tissue slice incubation method is needed to study nanoparticle-macrophage interactions in vivo-like conditions.

Purpose of the Study:

  • To develop and validate an in vitro spleen slice model for studying nanoparticle-macrophage interactions.
  • To elucidate the mechanisms underlying nanoparticle capture by splenic marginal zone macrophages.
  • To establish a reliable assay for evaluating nanoparticulate drug carrier interactions with the spleen.

Main Methods:

  • Development of an in vitro spleen tissue slice incubation method.

Related Experiment Videos

  • Incubation of spleen slices with nanoparticles in serum-supplemented and depleted media.
  • Assessment of nanoparticle uptake using various blocking agents and competitive ligands.

    • Main Results:

    • The in vitro model accurately reflects in vivo nanoparticle uptake profiles.
    • Complement, immunoglobulins, and heparin-binding proteins did not significantly affect nanoparticle capture.
    • Albumin substitution in serum allowed near-optimal uptake, and scavenger receptor blockers strongly reduced spleen capture.

    Conclusions:

    • The developed in vitro spleen slice assay is a valid method for studying nanoparticle-spleen interactions.
    • Nanoparticle capture by the spleen is a complex, multifactorial process.
    • Albumin and scavenger receptors play a significant role in the spleen's capture of nanoparticles.